Catalyst Wire Dossier Catalyst Wire Dossier

Hypertonic saline 3% inhalation

sodium chloride 3% inhalation solution
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hypertonic saline 3% inhalation, covering 2016-08-19 to 2016-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations [Phase 3]

See pricing